Comparative evaluation of two spinal anesthesia drugs for elective Cesarean section

A comparative evaluation of intrathecal hyperbaric levobupivacaine 0.5% with hyperbaric bupivacaine 0.5% for elective cesarean section : A prospective randomised study. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058567

Enrollment

Registered

2023-10-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: INTRATHECAL 0.5% HYPERBARIC LEVOBUPIVACAINE: All the patients will be screened before enrollment in study. Consent for participation in study will be obtained from patients.Group L (int

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant Females between age 18 to 40 years. 2. Patients belonging to ASA grade 1 and 2. 3. Subjects willing to sign informed consent for participation in study

Exclusion criteria

Exclusion criteria: 1. Patients under going caesearian section for fetal distress and hypertensive disorders of pregnancy. 2. Known allergy to the study drug 3. History of Liver, Renal & Cardiac diseases. 4. BMI > 30 5.Height 180cm

Design outcomes

Primary

Measure	Time frame
A COMPARATIVE EVALUATION OF INTRATHECAL HYPERBARIC LEVOBUPIVACAINE 0.5% WITH HYPERBARIC BUPIVACAINE 0.5% FOR ELECTIVE CESAREAN SECTIONTimepoint: 1.ONSET OF SENSORY BLOCK 2.MAXIMUM HEIGHT OF SENSORY BLOCK 3.DURATION OF SENSORY BLOCK 4.ONSET OF MOTOR BLOCK 5.DURATION OF MOTOR BLOCK	—

Secondary

Measure	Time frame
Hemodynamic parameters (Heart Rate and Mean Arterial Pressure). Side effects like nausea, vomiting, bradycardia and Hypotension. Neonatal APGAR scoreTimepoint: at the deliver of baby and throughout the surgery.	—

Countries

India

Contacts

Public ContactDR V M SASTURKAR

MGM MEDICAL COLLEGE AND HOSPITAL AURANGABAD

vasantims@rediffmail.com9370668196

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026